Awareness and Beliefs About Cervical Cancer, the HPV Vaccine, and Cervical Cancer Screening Among Ghanaian Women with Diverse Education Levels
Cervical cancer is the leading cause of cancer death among women in Ghana. Cost-effective tools for the primary and secondary prevention of cervical cancer, such as the Pap test, the HPV DNA test, and the HPV vaccine, are available in hospitals and clinics throughout Ghana. However, participation in cervical cancer prevention behaviors is low among Ghanaian women. Our objective was to determine if there were significant differences in cervical cancer awareness and stigmatizing beliefs about women with cervical cancer between Ghanaian women of different education levels. We surveyed 288 Ghanaian women who were at least 18 years old. Data on the participants’ demographic characteristics, awareness of cervical cancer, cervical cancer screening, and the HPV vaccine, beliefs about cervical cancer screening, and stigmatizing beliefs about women with cervical cancer was collected. Chi-square tests for independence and Fisher’s exact test of independence were preformed to determine if education level was associated with those factors. Participation in cervical cancer screening and uptake of the HPV vaccine was significantly lower among women with less than a senior high school education. Awareness about cervical cancer, cervical cancer screening, and the HPV vaccine was lower among women with less education. Women with lower levels of education were more likely to agree with the negative statements about cervical cancer screening and stigmatizing beliefs about women with cervical cancer. Cervical cancer education interventions that are tailored for Ghanaian women with different educational levels are needed to increase awareness of and participation in cervical cancer prevention strategies.
KeywordsCervical cancer prevention Ghana Women’s Health
Special thanks to the women who participated in this study. Sincere appreciation goes to Dorothy Kelly for supporting this study. Thank you to Chee Paul Linn for his assistance with the data analysis and Drs. Bettina Beech and Derek Griffith for their review of the manuscript. This project was supported by a Career Enhancement Award from the University of Alabama at Birmingham Office of Postdoctoral Education. The content is solely the responsibility of the authors and does not necessarily represent the official views of the author’s institutions.
Compliance with Ethical Standards
Approval to conduct this study was provided by the Institutional Review Boards at the University of Alabama at Birmingham (UAB) in Birmingham (X150218005), and the Noguchi Memorial Institute for Medical Research in Accra (077/14-15). The scientific protocol was approved by the UAB Comprehensive Cancer Center Protocol Review Committee.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Bruni L, Barrionuevo-Rosas L, Albero G et al (2017) Human papillomavirus and related diseases in Ghana. Summary report. In: ICO information centre on HPV and cancer (HPV information centre)Google Scholar
- 4.Forman D, Bray F, Brewster DH et al (eds) (2014) Cancer incidence in five continents. International Agency for Research on Cancer, LyonGoogle Scholar
- 13.Handlogten KS, Molitor RJ, Roeker LE, Narla NP, Bachman MJ, Quayson S, Owusu-Afriyie O, Adjei E, Ankobea F, Clayton A, Roberts L, MacLaughlin K, Ansong D (2014) Cervical cancer screening in Ghana, West Africa: prevalence of abnormal cytology and challenges for expanding screening. Int J Gynecol Pathol 33(2):197–202CrossRefPubMedGoogle Scholar
- 14.Laryea DO, Awuah B, Amoako YA, Osei-Bonsu E, Dogbe J, Larsen-Reindorf R, Ansong D, Yeboah-Awudzi K, Oppong JK, Konney TO, Boadu KO, Nguah SB, Titiloye NA, Frimpong NO, Awittor FK, Martin IK (2014) Cancer incidence in Ghana, 2012: evidence from a population-based cancer registry. BMC Cancer 14:362CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Denny L, Hendricks B, Gordon C, Thomas F, Hezareh M, Dobbelaere K, Durand C, Hervé C, Descamps D (2013) Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study. Vaccine 31:5745–5753CrossRefPubMedGoogle Scholar
- 17.(2014) Comprehensive cervical cancer control: a guide to essential practice. In. second ed. Geneva: World Health OrganizationGoogle Scholar
- 19.Williams MS, Kuffour G, Ekuadzi E et al (2013) Assessment of psychological barriers to cervical cancer screening among women in Kumasi, Ghana using a mixed methods approach. Afr Health Sci 13(4):1048–1055Google Scholar
- 23.Ebu NI, Mupepi SC, Siakwa MP, Sampselle CM (2015) Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana. Int J Women’s Health 7:31–39Google Scholar
- 25.Gavi (2013) Annual progress report 2012. In: GaviGoogle Scholar
- 28.Education and Literacy Statistics for Ghana. http://uis.unesco.org/en/country/GH